Interestingly, analyzing the three epigenetic modifiers together, we found that the simultaneous overexpression (3 +) of at least two of the three proteins (DNMT1, G9a, and UHRF1) in cancer cells resulted in a significant shorter DFS and OS when all PDAC patients were analyzed together (Fig. 1C). This evidence concerns the gene EHMT2 and cancer.